This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Gamida Cell Ltd.
Drug Names(s): CordIn
Description: Gamida Cell developed CordIn, a variation of NiCord, adapted for transplantation in patients with chronic non-malignant diseases. CordIn is allogeneic, umbilical cord blood-derived haematopoietic CD133+ cells.
Additional information available to subscribers only: